Lonza Group Investor Relations Material
Latest events
Q1 2025 TU
Lonza Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lonza Group AG
Access all reports
Lonza Group Ltd. engages in the manufacture and supply of products and services to the pharmaceutical, biotechnology, and diagnostic sectors. It operates through the Pharma & Biotech and Specialty Ingredients segments. The Pharma & Biotech segment includes active pharmaceutical ingredient active substances for therapeutic drugs for bacterial infections, anti-fungals, anti-virals, anti-cancer agents, cardiovasculars, gastrointestinal, and others. The Specialty Ingredients segment involves in the cosmetics ingredients business for personal care. Lonza Group was founded on December 5, 1897 and is headquartered in Basel.
Key slides for Lonza Group AG
H2 2024
Lonza Group AG
H2 2024
Lonza Group AG
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
LONN
Country
🇨🇭 Switzerland